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ABSTRACT
Background: Tuberculosis (TB) is still remains one of the main health problems globally.
Based on the 2013 WHO report there are 8.6 million new TB cases per year. In Ethiopia, TB
is responsible for major hospital admission and death like other TB endemic areas. Micro
nutrients and immune status are the main determinate factors of the incidence and the severity
of the disease in TB patients.
Objective: The main objective of this study was to determine serum zinc level and some
immunological variables such as Albumin level, CD4, CD8 monocyte and neutrophil in
newly diagnosed TB patients and healthy control group in Ethiopia.
Methods: A comparative cross- section study design was conducted from February to May
2014. Blood samples were taken from TB patients and controls for CD4, CD8, monocyte and
neutrophil determination. Zinc and albumin were determined in serum. Stool sample was
collected and examined for intestinal parasites microscopically using Formal ether
concentration technique.
Results: A total of 50 TB patients and 50 controls were included in the study. Among TB
patients 12(24%) were females and 38(76%) were males. The mean age of the study
participants was 29.96±9.27 with a range of 18-57years. The mean levels of serum zinc TB
Vs controls, (p=0.026), albumin of TB Vs control, (p<0.001) and CD4 of TB Vs control,
(p=0.007) of TB patients were significantly lower than the controls. The mean Neutrophil TB
Vs control, (p= 0.021) and monocyte levels TB Vs control, (p= 0.019) were higher in TB
patients compared to controls. Age, gender, and TB types didn’t show statistical association
with serum zinc, albumin, CD4, neutrophil and monocyte levels. But, CD4 level was
significantly associated with HIV infection. Increased levels of monocyte and CD8 level
were associated with Hook worm and schistosoma mansoni parasites, respectively.
Conclusion: The low level of zinc and other immunological parameters in TB patients
signify their role and importance to combat TB infection. An interventional study with
appropriate sample size and design is warranted to clearly show the role of micronutrient
during TB infection.
Key words; Albumin, CD4, CD8, Monocyte, Neutrophil, Tuberculosis and Zinc
11. INTRODUCTION
1.1. Global epidemiology of Tuberculosis
Tuberculosis (TB) is one of the major global health problems and in 2013 there were 8.6
million new TB cases and 1.3 million TB deaths (1). Of the reported deaths, 430,000 were
HIV positive TB patients The 2013 World Health Organization (WHO) TB reports for
different regions of the world shows that the south East Asian and African region show the
highest incidence. In this report the African region of smear positive new TB cases was
600,355(47%), smear negative new TB case 345.947(27%) and extra pulmonary new cases
234,539(18%) (2).
1.2. Tuberculosis in Ethiopia
Ethiopia is one of the 22 high burden countries. Based on the national TB prevalence survey,
smear positive TB among adults and all age group was found to be 108 and 63 per 100,000
populations, respectively. The prevalence of bacteriologically confirmed TB was found to be
156/100,000 populations and by extrapolations, the prevalence of all forms of TB in Ethiopia
is estimated to be 240/100,000 populations (3). In Ethiopia the incidence of TB cases as
WHO reported by 2013, shows that smear positive 47236(33%), smear negative 47.340(33%)
and extra pulmonary 46,854(33%) (1).The mortality and the incidence were 16 and 240 per
100 thousands of population, respectively. The HIV prevalence in incident of TB cases was
18 percent (4).
1.3. Bacteriology of Tuberculosis
Mycobactria are slender, curved rods that are acid fast and resistant to acid, alkalis and
dehydration. The cell well contains complex waxes and glycolipids. Multiplication on
enriched media is very slow; it multiplies within the time of 18 to 24 hours. On the basis of
growth rate, catalase and niacin production and pigmentation in light and dark,
mycobactrerial are classified in to members of mycobacterial tuberculosis complex (M.
tuberculosis , M bovis, M africanum and M microtii (5). Human TB is mostly caused by
Mycobacterium tuberculosis but M africanum and M bovies can be the cause too (6).
21.4. Host susceptibility of Tuberculosis
Environmental factor, host genetic factors and factors within the pathogen are important in
determining the progression of the disease (7). Large number of host genes are involved in
susceptibility and resistance of mycobacterium and other infection (8). Susceptibility to TB in
humans appears to be highly phylogenic with many loci implicated. Hetrogenecity of genetic
and allelic association is frequently observed when comparing results between populations
and has many causes including epistasis, where one gene interferes with or prevents
expression of the other located at different locus (9). This genetic susceptibility to
mycobacterial infection seen in tuberculosis can be explained by the host genes identified
(10).
The environmental factors associated with TB are poverty, overcrowding, alcoholism, stress,
drug addiction and mal nutrition. The disease is spread easily in overcrowding and badly
ventilated places among peoples who are under nourished (11). Co-infection with other
pathogens has also a great role in shifting and modulating the immune system. The clinical
response of TB depends on an effective Th1 immune response. Different studies have shown
that helminths co infected TB patients associated with increased interlukine-10 (IL-10),
regulatory T- cells (12). This indicates that co-infection with intestinal helminth could down
regulate the Th1 immune response required to combat TB infection.
1.5. Immune response to Tuberculosis
The TB associated glycolipid, lipoarabinomannan (LAM) and mycolic acid are responsible
for many immunological features. The bacilli is recognized by immune cells  through cell
receptors like macrophage receptors, surfactant receptors, FC recptors, complement receptors
and cluster of differentiation (CD1) molecules and DC-SIGN(13). Phagocytic cells play a key
role in the initiation and direction of adaptive T-cell immunity by presentation of
mycobacterial antigens and expression of costimulatory signals and cytokines. Alveolar
resident macrophages are the primary cell type involved in the initial uptake of TB. Then,
dendritic cells and monocyte derived macrophages also take part in the phagocytic process
(14). Collaboration between macrophages and T-cells is essential for eradication of TB
through antigen specific delayed type hypersensitivity response. Activated macrophage
presents TB antigens to lymphocytes (T) cells in association with MHC class II molecules
and macrophage derived cytokines play a critical role as co stimulatory molecules for antigen
3specific T cells. Subsequently cytokines produced by activated T cell for further modulation
of macrophages (15).
After phagocytosis of TB bacilli by macrophages and dendritic cells there is production of
IL-12 it is used to leads the development of a Th1 response with production of interferon-
gamma (IFN- γ) by T cell. Lymphocytes especially CD4+ T cells are the most important in
the protective response against TB (16). A major effector mechanism responsible for the anti
mycobacterial activity is IFN- γ, that induces the production of nitric oxide and related
reactive nitrogen intermediates (RNI) by macrophages via the action of the inducible form of
nitric oxide syntheses (NOS2) (17). Even if CD8 +T cells clearly cannot compensate for a
lack of CD4+ T cells it also contribute to anti M. tuberculosis immunity , potentially by
secreting IFN- γ to activate macrophages to control infection and by secreting products that
can directly kill the M. tuberculosis bacilli (18).
After TB infection a dynamic process begins for the formation of granuloma and
continuously evolves over time, the aggregation of white cells around the infected cells in the
alveoli. Granuloma divided in to three distinct phase. The innate Granuloma, formed by loose
aggregate composed primarily of recruited macrophage and neutrophil. The immune
Granuloma, formed by following the emergency of antigen specific T cell and ‘chronic
Granuloma, results from distinct morphological change in Granuloma structure. The
granuloma functions to limit the bacterial dissemination, but TB adapt to alter the immune
response within the granuloma creating suppressive environment by IL-10 (19).
1.6. Micronutrients against Tuberculosis
Tuberculosis has greater impact on countries with low socio-economic levels especially
affects labourers, and peoples living in overcrowded environment and poor housing (20).
Micronutrients take the major role in the development and maintenance of immune response,
and also affects both immediate and long term defence against infection and certain tumors
(21). The occurrence of malnutrition in individuals with latent TB is one of the triggering
factor for the development of active TB and it has been reported that malnutrition
compromise cell mediated immune response (22). Several micronutrients such as zinc,
vitamin A, riboflavin, folic acid, beta-carotene, vitamin B12, iron, Vitamin C, and selenium
have immune modulating functions and thus influence the course and outcome of diseases
and host susceptibility to infectious diseases (23).
4Zinc is one of the micronutrients which have many functions. It is the fundamental factor
determines the activity of many enzymes and forms the active enzymatic sites of many
metallo-proteases. It is essential to the function of DNA polymerase, thymidine kinase and
DNA dependent RNA polymerase. Zinc has also a great role in the activity of the
transcriptional regulator family, nominated as zinc finger DNA binding proteins (24). Zinc is
one of the basic requirements for the activity of some immune mediators. Thymulin is a
nonapeptidic hormone secreted by thymic epithelial cells that promotes T lymphocyte
maturation, cytotoxicity, and IL-2 production which requires the presence of zinc (25).
Decreased naive T cells production from the thymus and decreased CD4+ , CD45RA+ /CD4+
CD45RO+cells has been shown in zinc deficient individuals (26). Furthermore, zinc is useful
for Innate immune defence mechanism and the highly proliferative organ of the immune
system are influenced by zinc too (27).
The immune system is regulated mostly by zinc homeostasis in cells. Zinc deficiency results
in reduced antibody production for neoantigens because of B cell is more affected than
memory cells. Macrophage, granulocytes, and monocyte show reduced level of phagocytosis
and intracellular killing activates. Diminished recruitment and total number of Neutophil
reduction is shown in zinc deficiency (28).Th1 cytokines like IL-2, INF-γ and IL-12 which is
generated by stimulated macrophage and monocyte are zinc dependant. But on the other hand
Th2 cytokines are not affected by zinc deficiency with the exception of IL-10. IL-10
production is high during zinc deficiency in elderly individuals and simultaneously this
increasing has an adverse effect on Th1 and macrophage function (29).
Zinc is very important for the production of cells and proteins in adequate level as stated
earlier and the immune cells like CD4, CD8, monocyte and neutrophil are very crucial for our
immune system to combat TB infection. However, there is lack of information regarding zinc
level in association with some immunological markers and immune cells in Ethiopian TB
patients. Therefore, this study was designed to provide some information and fill some of the
gaps observed on the area.
52. LITREATURE REVIEW
The distinctive features of Zinc deficiency on immune system in human and in higher animal
are thyimic atrophy, compromised cell function, lymphopenia and increased rate and duration
of infection (30). These phenomena are supported by a number of research data in TB and
other infectious and non-infectious diseases.
A study done in Pakistan among 117 patients of newly diagnosed pulmonary tuberculosis, 89
(76.01%) were males and the mean zinc level was 9.24±0.92mmol/l. Only 8(6.84%) have
normal zinc level. Zinc level and sex of the study participant didn’t show a significant
association (p=0.220), but age was found significant (p=0.002) (31).
A study done in India on 20 TB and TB/HIV co infected patients. Their albumin and zinc
level was determined for the two groups, the mean albumin level was 2.9±0.4g/dl and
3.6±0.7 g/dl, the mean zinc level was 53.9±8 and 65.53± 9.8µg/dl for TB/HIV co infected
and TB patients respectively. Both zinc level and albumin level were significant (P < 0.001)
(32).
A study was done in India on 50 TB patients and 30 controls .In this study the mean serum
zinc level in TB patients was lower than the controls. A significant fall in zinc levels shown
when compared with that of the control group ( p <0.05) (33).
Other study done in USA in 85 TB patients, 43.5% showed low CD4 cell counts and 56.4%
patients had normal CD4 count. The CD8 cell count was lower in the patients with low CD4
cell counts than patients with normal CD4 cell counts (P <0.001). Total lymphocyte count
was also lower in patients with low CD4 cell counts than in patients with normal CD4 cell
counts. The CD4: CD8 ratio was similar in both control and study subjects (34).
A study showed that Zinc-deficient patients had significantly depressed albumin
concentrations of 3.23 ± 0.27 g/dl before zinc supplementation (p <0.001). This mean
increased to 3.95 ± 0.71 g/dl after zinc supplementation and was not statistically different
from the control group (4.02 ± 0.34 g/dl) (35)
A case control study matched for age and sex was conducted in Indonesia on 41 active TB
patients and 41 healthy control groups. The BMI in all patients was 20% lower than the
controls (p< 0.05), serum albumin concentration was 10% lower in TB patients than in
control(p<0.05) and plasma zinc concentration in patients were significantly lower than those
controls (p < 0.05)(36).
6A study was done in India among TB and TB/HIV co infected patients with that of control
groups. The CD4 count of the control (1773/ul) was much higher than TB patients (793/ul),
TB/HIV co-infected patients (379/ul) and HIV patients (550/ul). Serum albumin and zinc
level of the controls much higher than TB and TB/HIV co infected patients(37).
A study done in India on 39 TB patients, their CD4 counts is lower than when compared with
normal blood donors (p < 0.05), but the CD8 value in TB patients similar with the controls
(38)
A study done in Turkey among 75 active pulmonary TB, 25 inactive pulmonary and 20
healthy controls, the level of CD4 and CD8 counts in the active and inactive pulmonary TB
patients were lower compared to the health controls, with p value of ( P < 0.01) and (P
0.05),respectively (39).
A study done in India in TB patients with control groups, total lymphocyte and CD4 count
were done for both groups. The values of CD4 were 971±376 and 2223±333 of for patients
and controls, respectively (p=0.002).But CD8 value of both groups didn’t show difference.
(40).
A study done in Nigeria assessing the level of total protein and albumin in PTB patient they
have found out that the levels of albumin and total protein in TB patients was lower than the
controls. In the controls 8.38±1.1 and 4.99±0.5 and PTB patients 7.89±1.0 and 3.6±0.5 for
total protein and albumin, respectively( p < 0.05) (41).
A study done in South Africa on 43 newly diagnosed TB patients and the same amount of
controls, the mean zinc level was 59.49 ± 10.96 and 77.03± 14.88were, respectively, (p =
0.000) (42).
A study done in Uganda among health controls and TB patients, absolute monocyte level of
TB patients (2754±323) were higher than the controls (803±68) with (p <0.001), but CD4 and
CD8 cell of the TB patients were lower than the controls but didn’t show significant
association (43).
A study done in South Africa among controls and TB patients, CD4 count were significantly
depressed in TB patient relative to control subjects(P< 0·01). Absolute number of monocyte
and neutrophil count were elevated in the patients than the controls (p<0.01 and p<0.05).
7CD8 counts were lower in TB patients than controls but did not show significant association
(p= 0.13) (44).
A study done in Gondar Ethiopia among 112 newly diagnosed TB patients, 112 community
controls and 71 house hold contacts, the median and inter quartile range of the CD4 in
community control  750 and 627-923,( p=0.34). The house hold control CD4 median and
inter quartile were and 714and 578-825, (p= 0.012). Which has high level compared to the
TB patients’ CD4 median and inter quartile range were, 513 and 390-682 respectively (45).
Another study in Gondar Ethiopia, determination of micro nutrients’ among TB patients and
control groups , the mean serum zinc level of TB patients was lower than the controls (p<
0.05)(46).
83. RATIONAL OF THE STUDY
There is lack of information regarding the level of zinc, Albumin level, Immunological
markers and immune cells in TB patients in association with age, sex, body max index and
other determinate factors in Ethiopia. This paper aims to address some of the gaps in this
issue.
The findings of this work provide valuable information about the immunological markers,
zinc level and albumin level among TB patients when compared to control group. This will
be very vital information for the management of TB patients during treatment and follow up
in addition other clinical findings.
The findings of this work gives data for individuals who want to do further study on TB
patients to deal bout micro nutrients and immune status.
HYPOTHESIS
The working hypothesis of this study was the levels of Zinc, Albumin, CD4+Tcells,and
CD8+T cells are lower in TB patients than healthy controls but  immune cells (neutrophil and
Monocyte) are higher than the controls.
94. OBJECTIVES
4.1. General Objectives
 Measuring the levels of micronutrients, immunological markers and immune cells in
newly diagnosed TB patients and healthy controls.
4.2. Specific Objectives
 Measuring the serum zinc level in newly diagnosed TB patients and healthy controls.
 Measuring the albumin level in newly diagnosed TB patients and healthy controls.
 Measuring neutrophil and monocyte among the newly diagnosed TB patients and
healthy controls.
 Measuring the immunological markers such as CD4 and CD8, among TB patients and
healthy controls.
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5. MATERIAL AND METHODS
5.1. Study area
The study was conducted at Gondar University Hospital (GUH). GUH is a tertiary-level
teaching hospital located Northwest Ethiopia in Gondar town, which is 750 km far from
Addis Ababa. Gondar town has an elevation of 2135 meter above sea level. Taking into
account of the national population survey of 2007 the town currently would have more than
300,000 population (47).
5.2. Population
5.2.1. Source of population
Patients who visited the GUH for medical service were source of population.
5.2.2. Study population
All newly diagnosed TB patients who visited the TB treatment centre at GUH were the study
population and equivalent numbers of apparently healthy control groups who didn’t show any
kind clinical manifestation started from before three months.
5.3. Study design and period
It is comparative cross- sectional study that was conducted from February 2014 to May 2014
5.4. Inclusion and Exclusion criteria
5.4.1. Inclusion criteria
 Newly diagnosed TB patients
 Age 18-65 years
5.4.2. Exclusion criteria
 Chronic renal disease
 Chronic liver disease
 Malignancy / cancer
 Myocardial  infarction
 diabetes mellitus
 surgery during the last month
 Any acute injury ( wound)
 Patients taking zinc as medication
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5.5. Study variables
5.5.1. Dependant variables
 Zinc level
 Albumin level
 CD4+ cell level
 CD8+ cell  level
 Monocyte cell level
 Neutophil cell level
5.5.2. Independent variables
 Age
 Sex
 Occupation
 Level of Education
 BMI
 Residence
 HIV
 Smear positive tuberculosis
 Smear negative tuberculosis
 Extra pulmonary  TB
 Intestinal parasites
5.6. Sample size and Sampling techniques
It was a coverage survey in that all newly diagnosed TB patients who were diagnosed and
visited the DOTS centre for TB treatment at the GUH during the study period and those who
fulfilled the inclusion criteria were included in the study. Convenient sampling technique was
applied.
5.7. Data collection and laboratory methods
Blood and stool samples were collected from the study participants. Ten ml of blood
collected and of these 5 ml was used for the determination of CD4-T cells and CD8-Tcells
levels using FACS Calibur machine and also used for haematological analysis. Five ml blood
12
was used for chemistry and serum zinc level measurement. The stool sample was examined
microscopically using Formol ether concentration technique for intestinal parasites.
5.7.1. Laboratory methods
Flow cytometry
Surface marker staining of the lymphocytes (CD4 and CD8), were done by using by using
specific monoclonal antibody, conjugated with fluorochrome day. The automated machine
analyzed and counted the stained mono nuclear cells from the peripheral whole blood. The
FACS calibur machine used BD cell Quest software for analysis (48).
Albumin determination
Serum albumin was determined after serum was separated in clinical chemistry laboratory.
By using Bromcresol Green (BCG) method, Albumin in the serum sample mixed with the
reagent that hold BCG chemical for the development of colored complex. The absorbance of
the colored complex at 628nm directly proportional to the concentration of albumin in serum
up to the linear limit of the method (49).The absorbance of the mixture was taken by
MindrayBS200 full automated analyzer, and the result was obtained by multiplication of the
absorbance value with the factor (50).
Zinc level determination
Serum sample for zinc determination was diluted in distilled water by using calibrated micro
pipette in to1:10 diluted sample (51). In Atomic Absorption Spectroscopy (AAS) machine,
the diluted sample converted in to atoms by atomization using acetylene gas. Zinc hollow
cathode lamp was used as a light source .During atomization the valence electron of zinc
atom, fluctuate from ground state to excited state. The ground state zinc atom absorb the light
that come from the hollow cathode lamp, which had the same characteristic of wave length as
emitted zinc electron returning from the exited state to the ground state. The intensity of the
absorbed light is proportional to the concentration of zinc atom in the atomized solution. Five
serially diluted know standard solution was done to develop factor, the level  of zinc in the
sample was obtained by multiplication of the developed factor from the standard  with  the
absorbance of  the sample  and the dilution factor (52).
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Total Monocyte and Neutrophil counts
The total monocyte were counted by Beckman Coulter ACT diff machine (53) and neutrophil
count were done by using cell Dyn 1800 haematological analyzer from whole blood. Both
The Cell-Dyn 1800 Haematology Analyzer and Beckman Coulter machine performs a
Complete Blood Count (CBC) by using Electrical impedance principle (54).
Stool Examination
Stool examination was done by formal ether concentration technique. The patients were well
oriented to bring appropriate sample volume and as much as they can to kept the sample from
toilet contaminations. All the samples were preserved immediately by 10% formalin until
examination. During concentration procedure the entire preserved sample we used as whole,
microscopic reading was done by preparing two slides from single sample sediment by two
laboratory technologists (55).
Body max index (BMI) of the study participants were calculated after taking weight and
height. Classification was done based on WHO classification method(56). The age of the
study participants were classified based on Sturges rule(57).
5.8. Quality controls
The entire instrument used (AAS, MindrayBS200, Beckman Coulter ACT diff, Cell- Dyn
1800 and Facs Calibur) were under the regular daily, weekly and monthly maintenance.
Standard Operating Procedures (SOPS) were strictly followed during sample collection and
handling, sample processing and analysis. Calibration was done when new batch of reagent
applied before running quality control material. Quality control tests were run before running
the test samples and latter the samples were run after verifying the quality control results.
The standardized questioners were prepared for collecting socio-demographic and clinical
data, in English and Amharic language. All the collected data including laboratory finding
was cheeked for completeness and entered to a computer on Statistical Package for Social
sciences (SPSS) software (version 20)
5.9. Data analysis and interpretation
Descriptive statistics was used and the results were described as mean + SD. Parametric tests
such as student t-test and ANOVA were done for evenly distributed variables to assess the
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the influence of age, sex, BMI and type of TB. For non-evenly distributed variables non-
parametric tests such as, Mann-Whitney U test and Kruskall-walls tests were used. Variables
with a p value < 0.05 was considered as statistically significant, all statistical analysis done by
SPSS software (version 20)
5.10. Result dissemination
The final results have been disseminated to School of Biomedical and Health Science,
University of Gondar, to University of Gondar hospital TB clinic. The findings will be
written in manuscript form and will be submitted to a reputable journal for wider
dissemination
5.11. Ethical consideration
Ethical approval was obtained from the ethics committee of the University of Gondar,
Collage of Medicine and Health Sciences. Informed consent also obtained from all study
participants.
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6. RESULTS
Recruitment of study participants
A total of 100 study participants were included from February to May 2014. Of these, 71
were males and 29 were females. Seventy five participants were coming from urban area and
the remaining 25 came from rural area.
Of the total 100 participants involved in this study, 50 were confirmed new TB patients cases
and equal numbers of apparently healthy control individuals were recruited for comparison.
The mean ± SD age of the total study participants included in this study was 29.9 ±9.3 years
with range of 18-57 years. From the 50 TB patients included in this study 4 individuals were
co-infected with HIV but they have not started anti retroviral therapy. Of the TB patients 66%
(33/50) were pulmonary TB cases and the rest 36% (17/50) were patients with extra
pulmonary TB. From the total Pulmonary TB patients 42% (14/33) were smear positive TB
cases while 58% (19/33) were smear negative TB patients.
6.1. Socio demographic characteristic of study participants
From the total TB patients 12(24%) were females and 38(76%) were males. 24(48%) were
farmers and 36 (72%) were not educated. (Table- 1)
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Table 1. Socio demographic characteristic of the newly diagnostic TB patients and controls
in Gondar, North west Ethiopia, 2014.
Variables TB patients Controls
Gender
Females
Males
12(24%)
38(76%)
17(38%)
33(62%)
Residence
Rural
Urban
25(50%)
25(50%)
0(0%)
50(100%)
Occupation
Farmer
Daily labourer
Office work
House wife
Merchant
Student
25(50%)
9(18%)
2(4%)
7(14%)
3(6%)
4(8%)
0(0%)
2(4%)
34(68%)
0(0%)
0(0%)
14(28%)
Level  of education
Uneducated
High school
Diploma
First degree
Above first degree
36(72%)
9(18%)
4(8%)
1(2%)
0(0%)
0(0%)
4(8%)
11(22%)
29(58%
6(12%)
Religion
Orthodox
Muslim
Protestant
45(90%)
0(0%)
5(10%)
42(84%)
3(6%)
5(10%)
Total no of participants 50 50
17
6.2. Prevalence of intestinal parasites
Form stool examination Hook.worm was the most prevalent (34%) parasites identified in TB
patients.
Table 2. Prevalence of intestinal parasites in patients with active tuberculosis. Gondar,
Northwest Ethiopia.2014
6.3. Level of zinc, Albumin, immunological markers and immune cells
The mean serum zinc level was 12.52±5.98µmol/l and 17.29±9.58 µmol/l in TB patients and
controls, respectively.  The mean Zinc, Albumin and CD4+ cell levels were significantly
lower in TB patients compared to controls, but the mean monocyte, CD8 and neutrophil were
the reveres (Table 3).However CD8+ cell level didn’t show any significant association.
Intestinal parasite Pulmonary TB Extra
pulmonary TB
N (%)Smearpositive
N (%)
Smear
negative
N (%)
Total
N (%)
Hook worm
Positive
Negative
7(14%)
7(14)
5 (10%)
14(28%)
12(24%)
21(42%)
5(10%)
12 (24%)
Schistsoma Mansoni
Positive
Negative
2(4%)
12(24%)
4(8%)
15(30%
6 (12%)
27(54%)
2 (4%
15(30%)
Ascharise lubricoide
Positive
negative
2(4%)
12(24%)
6(12%)
13(26%)
8(16%)
25(50%)
1(2%)
16(32%)
Stronglid.Stercolares
Positive
Negative
1(2%)
13(26%)
1(2%)
18(36%)
2(4%)
31(62%)
0 (0%)
17 (34%)
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Table 3. Level of zinc, Albumin, CD4 CD8, Monocyte, and Neutrophil in TB patients and
healthy controls in Gondar, Northwest Ethiopia 2014.
The mean of Albumin, CD4, CD8, Monocyte and Neutrophil didn’t show any statistical
significant with sex with the p-value of 0.654, 0.403, 0.660, 0.893 and 0.893, respectively.
The forms of TB didn’t show any statistical association with levels of zinc, albumin, CD8,
monocyte and neutrophila (Table 4). Interestingly the CD4 level was significantly lower in
pulmonary TB patients compared to extra pulmonary TB (p=0.001) (Table 4)
Table 4. Levels of zinc, Albumin, CD4, CD8, Monocyte and Neutrophil with forms of TB
and type of pulmonary TB. Gondar, Northwest Ethiopia, 2014.
Pulmonary TB Extra
pulmonary
TB
(mean+SD)
p-value* p-value**
Smear +
(mean+SD)
Smear –
(mean+SD)
Total
(mean+SD)
Zinc 10.9±6.0 12.9±6.2 12.2±6.0 12.95±6.15 0.263 0.631
Albumin 3.0±1.2 2.6±1.5 2.8±1.4 2.7±1.1 0.354 0.440
CD4 491±149 609±225 559±203 780±420 0.180 0.000
CD8 812±857 601±379 690±625 728±665 0.788 0.992
Monocyte 607±304 436±192 509±256 429±309 0.123 0.214
Neutrophil 4914±2367 5742±4874 5390±3976 5464 ±2912 0.760 0.674
*p-value between smear + and smear – TB
** P-value between Pulmonary TB (Total) and extra pulmonary TB
TB
(mean± SD)
n=50
Controls
(mean ±SD)
n=50
P value
Zinc 12.5±5.9 17.2±9.5 0.026 (Mann-Whitney U test)
Albumin 2.7±1.3 5.3±0.6 0.000 (t-test)
CD4 634±309 997±861 0.007 (t-test)
CD8 703±632 618±255 0.659 (Mann-Whitney U test)
Monocyte 482±275 382±281 0.019 (Mann-Whitney U test)
Neutrophil 5416±3619 3964±1653 0.021 (Mann-Whitney U test)
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From the total TB patients 56% were having BMI < 18.5kg/m2 but only 26% of the controls
were having lower BMI (<18.5kg/m2).  However there was no any association between BMI
levels with Zinc, Albumin, CD4, CD8, Monocyte and neutrophil levels (Table 5). However,
there was significant association between CD4 counts with BMI level, CD4 level of TB
patients with BMI of < 18.5 kg/m2 lower than TB patients with BMI of 18.5-24.9kg/m2 (p =
0.047).
Table 5. Level of zinc Albumin CD4, CD8, monocyte and neutrophil with BMI in TB
patients Gondar, Northwest Ethiopia, 2014
BMI(<18.5kg/m2 ) BMI(18.5-24.9kg/m2) P- value
Zinc 13.78±6.04 11.27±5.86 0.241 (Mann-Whitney U test )
Albumin 2.61±1.33 2.99±1.29 0.367(t –test)
CD4+ Tcell 553. 39±237.91 737.72±361.78 0.047( t –test )
CD8+T cell 598.67±377.79 837.05 ±510.5 0.725( Mann-Whitney U test)
Monocyte 464.28±243.75 504 .54±315.43 0.767 (Mann-Whitney U test)
Neutrophil 5342.85±4457.82 5416.00±3619.24 0.207 (Mann-Whitney U test)
(Zinc= µmol/l, Albumin=mg/dl, CD4&CD8=cell/µl)
As shown in table 6, like that of sex there is no any significant association in the levels of
Zinc, Albumin. CD4, CD8, monocyte and neutrophil with age group.
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Table 6. Level of Zinc, albumin, CD4, CD8, Monocyte and Neutrophil with age group Of TB
patient. Gondar Northwest Ethiopia,  2014.
(Mo = monocyte, Neu = neutrophil, Zinc= µmol/l, Albumin=mg/dl, CD4&CD8=cell/µl)
6.4. Association of intestinal parasites and HIV with zinc, albumin, CD4, CD8,
monocyte and neutrophil
Zinc and neutrophil didn’t show any association with intestinal parasite and HIV, but as table
7 showed that their association between albumin and Hook worm (p-0.025), the mean
albumin level is lower in Hook Worm positive than negative TB patients.CD4 and HIV (p <
0.001), CD8 and schstosoma mansoni (0.023) and monocyte with Hook worm (0.029), the
mean monocyte level in Hook Worm positive were higher than in negative patients.
Age
group 18-22 23-27 28-32 33-37 38-42 43-47 48-52 53-57
P
value
Zn 12.9±6.7 12.9±6.7 10.9±6.7 14.1±6.4 12.9±6.7 10.9±6.7 10.9±6.7 12.9±8.3 0.832
Alb 2.5±1.0 2.9±1.01 2.9±1.9 2.7±1.3 2.9±1.6 2.0±1.3 3.5±1.5 3.2±0.8 0.863
CD4 840±339 603±215 674±459 595±332 426±205 573±160 718±152 525±97 0.504
CD8 601.±213 1118±1121 964±944 659±587 498±337 578±148 466.±277 485±289 0.804
Mo 380.±204 671±275 671±407 400.±217 442.±237 425.±287 566±115 266±152 0.175
Neu 5310±3057 6671±2877 4500±1163 5155±912 6542±7949 6850±3321 3666±2948 2966±929 0.206
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Table 7. Level of zinc, albumin, CD4+ cell, CD8+cell, monocyte and neutrophil with intestinal parasite and HIV Gondar Northwest
Ethiopia.2014
(Mo=monocyte,Neu=Neutrophila,Zinc=µmol/l,Albumin=mg/dl,CD4&CD8=cell/µl)
Hook worm Schist soma mansoni. Ascaris.lumbricoied. Strongyloide.stercolaries HIV
Positive
n=17
Negative
n=33
P value Positive
(n=8)
Negative
(n=42)
p-value Positive
(n =9 )
Negative
(n=41)
p-valuePositive
(n=2)
Negative
(n=48)
p-value Positive
(n= 4 )
Negative
(n= 46)
p-value
Zn 10.6±5.7 13.6±6.0 0.555 12.9±8.3 12.4±5.9 0.894 9.0±4.8 13.5±6.0 0.236 12.9±8.3 12.5±5.9 0.894 14.9±6.7 12.2±5.9 0.780
Alb 2.7±1.7 2.8±1.0 0.025 3.2±1.6 2.7±1.2 0.145 3.0±1.4 2.7±1.3 0.949 3.0±0.3 2.8±1.3 0.138 2.4±0.7 2.8±1.3 0.546
CD4 722±357 588±276 0.139 569±276 834±409 0.069 689±236 622±324 0.420 386±42 645±311 0.197 214±158 671±293 0.00
CD8 653 ±657 739±638 0.661 1072±834 633±572 0.023 481±159 752±681 0.356 766±412 700±630 0.558 1166±751 663±614 0.153
Mo 582±273 430±266 0.029 550±358 469±259 0.427 422±238 495±283 0.426 450±71 483±280 0.940 425±170 486±283 0.850
Neu 5788±5416 5224±2375 0.525 5647±3825 4200±1991 0.223 7177±6724 5029±2479 0.318 5400±2121 5416±3682 0.686 5500±2290 5408±3729 0.593
22
7. DISCUSSION
This study assessed the level of zinc, Albumin, CD4, CD8, monocyte and neutophil in TB
patients and the findings were compared with controls groups. The mean concentration of
serum zinc level, Albumin, CD4 level were significantly lower in TB patients compared to
controls. On the other hand, TB patients showed high Monocyte, Neutophil and CD8 cells
levels than controls.
The low serum zinc concentration in TB patient in this study is in agreement with a  study
done in Pakistan (31), India (32) Indonesia (58). The probable cause for the lower serum
zinc level in TB patients might be due to the reduction of zinc carrier proteins, α2 -
macroglobulin and or a rise in the production of metallothionein, a protein that transports zinc
to the liver. The other probable reason could be nutritional factor as reflected in the BMI
value in that large percentage of the TB patients were having BMI <18.5 compared to
controls. Lower Zinc level may have an impact on macrophages functions such as
phagocytosis, intracellular killing, cytokines production and, growth and function of T cells.
Thus considering the fact that these immunological mechanisms are so vital to combat TB
infection the lower level of zinc reported in this study raise a great concern.
In mice model it was  demonstrated that  zinc-deficient mice faced thymic atrophy,
reductions in absolute number of splenocytes and depressed responses to both T-cell-
dependent (TD) and T cell-independent (TI) antigens (59). In experimental human model
zinc deficiency was correlated with lower IFN-γ production , where as the production of IL-
4, IL-6, and IL-10 was not affected because of zinc deficiency (60). It is known that IFN-γ
production is vital to combat TB infection. Even though this study didn’t measure IFN-γ level
the low zinc level observed in TB patients compared to healthy controls in the present study
supports this fact. The association between gender with serum zinc level was assessed in
patients with pulmonary tuberculosis. No significant association between gender and serum
zinc level was observed in this study which is in agreement with a study done in Pakistan
and India (31, 61). Furthermore other studies from Ethiopia (46) and India(62) was didn’t
show any association between serum zinc level with gender.
Albumin was significantly lower in newly diagnosed TB patients compared to the control
group. The same finding was reported  in Nigeria which demonstrated that three important
nutritional indices (transferrin, total protein and albumin), were significantly lower in TB
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patients compared to controls (41). The probable cause may be serum albumin concentration
in malnourished patients is lower than that in well-nourished healthy controls. And also it
was reported that TB patients with lower BMI exhibited  lower albumin level (36).the other
probable cause may be  that the hepatic synthesis of acute phase proteins is induced by
cytokines such as interleukin-6 and tumor necrosis factor which inhibit the production of
serum albumin and cause dramatic shifts in the plasma concentration of certain essential
micro nutrients and albumin (63). It is obvious that the production of certain cytokines such
as IL-6 and TNF-α is increased during TB patients and this fits with the observed findings.
The level of CD4+ cells was also significantly lower in TB patients compared to control
group. Similar findings were reported in different studies conducted  in USA (34),  India (37)
and Ethiopia (45). Animal model study demonstrated   that low CD4 count could be one of
the main factor exacerbating development of active TB (64). It is well known that CD4+
lymphocytes are one of the main immune cells in cell mediated immune system that  plays a
great role to contain and kill TB bacilli (65). Its primary function is believed to be the
production of IFN- γ and other cytokines to activate macrophages, which can then control or
eliminate intracellular organisms such as TB baccilli (17). The main reason for having lower
CD4 count in TB patients might be due to co-infection with HIV as the finding of this paper
also demonstrated. It is clearly known that HIV co-infection rate is high in TB endemic areas
and this will lead to have lower CD4 count as HIV mainly destroys these cells. The other
probable reason might be due to low micro nutrients like zinc which is an essential micro
nutrient for the development and function of important immune cells.
This study showed that the mean CD4 level of pulmonary patients was lower than extra
pulmonary TB patients and showed significant association. Other findings were in the
contrary (66, 67), the probable cause may be the prevalence of HIV in our TB patents much
less than the others.
The mean CD8 cell level of TB patients was high when compared to controls but the
difference was not statistically significant. This finding is in agreement with a study done by
Afzal N et al (68) , Figen  D, et al (39) and Gariby E, et al (69) and different from a study
done by Handan H et al (68) and Thomas Cyt et al (70). Even if there was no association
between CD8 level with TB patient, high level CD8 might be due to due to chronic parasite
co infection, in addition to this our finding showed that significant association of schistosoma
mansoni with CD8 level in TB patients.
24
In the present study, higher neutrophil count was observed and it was associated with TB.
Similar findings were observed in a study done in Pakistan (71) and in Nigeria (72). However,
this finding didn’t ascertain whether increased neutrophil counts resulted from an increased in
absolute numbers of neutrophil in the body or from trafficking of neutrophil in to the blood.
The other probable cause of increased blood neutrophil level during TB infection might be
due to noon specific inflammatory response of tissue damage during TB infection. Increasing
blood neutrophil may not have a great role in combating TB infection because of a short life
span and the bacilli grow in macrophages. As previously reported that  increased neutrophil
counts are common among patients with active TB disease in the context of poorly
functioning acquiring immune response reported (73). The other probable reason might be
the decreasment of production of INF-γ during TB infection. Because INF-γ inhibits the
production of IL- 17 and other pro inflammatory cytokines, which are regulate neutrophil
recruitment. Due to this neutrophila during TB infection may indicate loss or failed the Th1
immunity or INF-γ responsiveness. Study also showed that patient with grater sputum
mycobacterium burden show high neutrophila (74).
In addition, monocyte in TB patients was higher compared to controls and the difference was
statistically significant. This was similar with a study done in South Africa (44), and Saudi
Arabia (75). Monocytes are the progenitor cell for macrophages and dendritic cells.
Macrophage and dendritic cells is the main cell types involved during phagocytosis,
production of nitric oxide species and IL-12 which is very important for activation of CD4
cell.  The probable reason for blood level monocyte increase may be because during TB
infection dramatically monocyte differentiation and acquisition in to effecter function are
altered. The other possible reason might be the inflammatory cytokines like TNF-α
production by the damaged tissue during TB infection cause monocytosis and monocytosis
may be also due to the shifting of monocyte sub population from CD16 - monocyte in to
CD16+. CD16+ type monocyte cells are poorly differentiated in to functional dendritic and
macrophages, due to this blood monocyte level increased during TB infection.
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8. CONCLUSION
Our study demonstrate that TB patients have low serum zinc level, albumin level and CD4+
T cell level when compared to the control groups on which all of them show significant
association. On the other hand CD8+T cell monocyte neutrophil level in TB patients was
higher than the control groups, but only CD8+ T cell didn’t show any significant association.
Interestingly, CD4+T cell levels significantly varied between pulmonary versus extra
pulmonary TB in that significantly lower CD4+T cell level was observed in pulmonary TB
patients. This statistical difference was not seen for other parameters such as zinc albumin,
CD8, monocyte and neutrophil In addition, level of CD4+ T cell was associated with BMI,
but no association was seen among age and gender with zinc, albumin, CD4+Tcell , CD8+T
cell, monocyte and neutrophil. Hook worm was the prevailing intestinal parasites examined
followed by Schistosoma Mansoni. From the dependant variables albumin and monocyte
were show association with monocyte and CD8 show association with Schistosoma Mansoni.
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9. RECOMMENDATION
 Zinc, albumin, and CD4 determination should be used as additional diagnostic tool
for TB patients
 The low zinc level in TB patients compared to controls may urge the need for zinc
supplementation.
 An interventional randomized study with zinc and nutritional supplementation is
recommended to see the mere effect of supplementations to prevent TB disease and to
evaluate its probable role for faster prognosis.
 The mechanism behind of significant difference in CD4 levels between PTB and
EPTB should studies further.
 Moncytosis and Neutrophila in the blood of TB patients and their role for tissue reside
intracellular pathogen should be Study.
 The high Hook worm rate in TB patients and its bad effect on vulnerable populations
alerts the need to devise and promoting prevention tools such as improving personal
hygiene and shoe wearing habit.
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10. LIMITATIONS OF THE STUDY
The sample size and not being age sex matched in the study may have an influence on the
power of the study.
28
11. REFERANCES
1. World Health Organization. Global tuberculosis report .2013.
2. World Health Organization. Global tuberculosis control ,Geneva. 2011.
3. Federal Menistry of Health . Guidelines for clinical and programmatic management of
TB, TB/HIV and Leprosy in Ethiopia. 2013.
4. OWorld Health Organization . Global tuberculosis report. Geneva. 2012.
5. Levinson W, Jawetz E. Medical microbiology and immunology: examination and board
review: Appleton & Lange; 1996.
6. Welin A. Survival strategies of Mycobacterium tuberculosis inside the human
macrophage: Linköping; 2011.
7. McShane H. Susceptibility to tuberculosis–the importance of the pathogen as well as the
host. Clinical & Experimental Immunology. 2003;133(1):20-1.
8. Bellamy R. Identifying genetic susceptibility factors for tuberculosis in Africans: a
combined approach using a candidate gene study and a genome-wide screen. Clinical
Science. 2000;98(3):245-50.
9. YIM JJ, Selvaraj P. Genetic susceptibility in tuberculosis. Respirology. 2010;15(2):241-
56.
10. Bellamy R. Susceptibility to mycobacterial infections: the importance of host genetics.
Genes and immunity. 2003;4(1):4-11.
11. Farmer P, Robin S, Ramilus S-L, Kim JY, editors. Tuberculosis, poverty, and"
compliance": lessons from rural Haiti. Seminars in Respiratory Infections; 1991.
12. Resende Co T, Hirsch C, Toossi Z, Dietze R, Ribeiro‐Rodrigues R. Intestinal helminth
co‐infection has a negative impact on both anti‐Mycobacterium tuberculosis immunity
and clinical response to tuberculosis therapy. Clinical & Experimental Immunology.
2007;147(1):45-52.
13. Collins HL, Kaufmann SH. The many faces of host responses to tuberculosis.
Immunology. 2001;103(1):1-9.
14. Van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium
tuberculosis. Clinical Microbiology Reviews. 2002;15(2):294-309.
15. Fenton MJ, Vermeulen MW. Immunopathology of tuberculosis: roles of macrophages
and monocytes. Infection and immunity. 1996;64(3):683.
16. Raja A. Immunology of tuberculosis. The Indian journal of medical research.
2012;136(1):0.
29
17. Flynn JL, Chan J. Immunology of tuberculosis. Annual review of immunology.
2001;19(1):93-129.
18. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune
response in tuberculosis. Annual review of immunology. 2013;31:475-527.
19. Shaler CR, Horvath CN, Jeyanathan M, Xing Z. Within the Enemy’s Camp: contribution
of the granuloma to the dissemination, persistence and transmission of Mycobacterium
tuberculosis. Frontiers in immunology. 2013;4.
20. Cramm JM, Koolman X, Møller V, Nieboer AP. Socioeconomic status and self-reported
tuberculosis: A multilevel analysis in a low-income township in the Eastern Cape, South
Africa. Journal of Public Health in Africa. 2011;2(2):e34.
21. Cunningham-Rundles S, McNeeley DF, Moon A. Mechanisms of nutrient modulation of
the immune response. Journal of Allergy and Clinical Immunology. 2005;115(6):1119-28.
22. Papathakis P, Piwoz E. Nutrition and Tuberculosis: A review of the literature and
considerations for TB control programs. United States Agency for International
Development, Africa's Health 2010 Project. 2008:1.
23. Bhaskaram P. Micronutrient malnutrition, infection, and immunity: an overview.
Nutrition reviews. 2002;60(s5):S40-S5.
24. McCall KA, Huang C-c, Fierke CA. Function and mechanism of zinc metalloenzymes.
The Journal of nutrition. 2000;130(5):1437S-46S.
25. Dardenne M, Pléau J-M, Nabarra B, Lefrancier P, Derrien M, Choay J, et al. Contribution
of zinc and other metals to the biological activity of the serum thymic factor. Proceedings
of the National Academy of Sciences. 1982;79(17):5370-3.
26. Prasad AS. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. Journal of
Infectious Diseases. 2000;182(Supplement 1):S62-S8.
27. Wellinghausen N, Rink L. The significance of zinc for leukocyte biology. Journal of
Leukocyte Biology. 1998;64(5):571-7.
28. Rink L, Haase H. Zinc homeostasis and immunity. Trends in immunology. 2007;28(1):1-4.
29. Prasad AS. Zinc: role in immunity, oxidative stress and chronic inflammation. Current
Opinion in Clinical Nutrition & Metabolic Care. 2009;12(6):646-52.
30. Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu
Rev Nutr. 2004;24:277-98.
31. Uttra CKM, Devrajani BR, Shaikh HM, Shah SZA, Devrajani T, Shaikh N, et al. Serum
Zinc Level in Patients with Pulmonary Tuberculosis. Advances in Biological Research.
2011;5(3):174-8.
30
32. Ramakrishnan K, Shenbagarathai R, Kavitha K, Uma A, Balasubramaniam R,
Thirumalaikolundusubramanian P. Serum zinc and albumin levels in pulmonary
tuberculosis patients with and without HIV. Japanese journal of infectious diseases.
2008;61(3):202.
33. Ghulam H, Kadri SM, Manzoor A, Waseem Q, Aatif MS, Khan GQ, et al. Status of zinc
in pulmonary tuberculosis. The Journal of Infection in Developing Countries.
2009;3(05):365-8.
34. Jones BE, Oo MM, Taikwel EK, Qian D, Kumar A, Maslow ER, et al. CD4 cell counts in
human immunodeficiency virus—negative patients with tuberculosis. Clinical Infectious
Diseases. 1997;24(5):988-91.
35. Bates J, McClain C. The effect of severe zinc deficiency on serum levels of albumin,
transferrin, and prealbumin in man. The American journal of clinical nutrition.
1981;34(9):1655-60.
36. Karyadi E, Schultink W, Nelwan RH, Gross R, Amin Z, Dolmans WM, et al. Poor
micronutrient status of active pulmonary tuberculosis patients in Indonesia. The Journal
of nutrition. 2000;130(12):2953-8.
37. Muthuraj M, Kamatchiyammal S, Usharani B, Manupriya S, Ayyappan AN,
Divyalakshmi K. Serum zinc, calcium and albumin levels in pulmonary tuberculosis
patients co-Infected with HIV. Global Journal of Biotechnology & Biochemistry.
2010;5(1):27-35.
38. Uppal S, Tewari S, Verma S, Dhot P. Comparison of CD4 and CD8 lymphocyte counts in
HIV‐negative pulmonary TB patients with those in normal blood donors and the effect of
antitubercular treatment: Hospital‐based flow cytometric study. Cytometry Part B:
Clinical Cytometry. 2004;61(1):20-6.
39. Deveci F, Akbulut HH, Celik I, Muz MH, Ilhan F. Lymphocyte subpopulations in
pulmonary tuberculosis patients. Mediators of inflammation. 2006;2006.
40. Swaminathan S, Nandini K, Hanna L, Somu N, Narayanan P, Barnes P. T-lymphocyte
subpopulation in tuberculosis. Indian pediatrics. 2000;37(5):489-95.
41. Adedapo K, Arinola O, Ige O, Adedapo A, Salimonu L. Combination of reduced levels of
serum albumin and αlpha-2-macroglobulin differentiates newly diagnosed pulmonary
tuberculosis patients from patients on chemotherapy. African Journal of Biomedical
Research. 2006;9(3).
31
42. Lombardo CC. The nutritional status of patients with tuberculosis in comparison with
tuberculosis-free contacts in Delft, Western Cape. South African Journal of Clinical
Nutrition. 2012;25(4):180-5.
43. Hertoghe T, Wajja A, Ntambi L, Okwera A, Aziz M, Hirsch C, et al. T cell activation,
apoptosis and cytokine dysregulation in the (co) pathogenesis of HIV and pulmonary
tuberculosis (TB). Clinical & Experimental Immunology. 2000;122(3):350-7.
44. Veenstra H, Baumann R, Carroll N, Lukey P, Kidd M, Beyers N, et al. Changes in
leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of
CD3dimCD56+ natural killer T cells in fast treatment responders. Clinical &
Experimental Immunology. 2006;145(2):252-60.
45. Abate E, Belayneh M, Gelaw A, Idh J, Getachew A, Alemu S, et al. The impact of
asymptomatic helminth co-infection in patients with newly diagnosed tuberculosis in
north-west Ethiopia. PloS one. 2012;7(8):e42901.
46. Kassu A, Yabutani T, Mahmud Z, Mohammad A, Nguyen N, Huong B, et al. Alterations
in serum levels of trace elements in tuberculosis and HIV infections. European Journal of
Clinical Nutrition. 2006;60(5):580-6.
47. Commission FDRoEPC. Summary and statistical report of the 2007 population and
housing census–population size by age and sex. Addis Ababa, December. 2008.
48. Sutherland DR, Nayyar R, Acton E, Giftakis A, Dean S, Mosiman VL. Comparison of
two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur
and FACSCanto flow cytometers. Cytotherapy. 2009;11(5):595-605.
49. Pinnell AE, Northam BE. New automated dye-binding method for serum albumin
determination with bromcresol purple. Clinical chemistry. 1978;24(1):80-6.
50. Abs P, Spline R. MINDRAY BS-120/BS-200E APPLICATION. CAL.1:3.0.
51. Syed Fahad Akbar Ali, Nida Imtiaz a, Mehdi SU. Analysis of Zinc in Human Blood
Using Flame Atomic Absorption Spectroscopy (FAAS). Biological and Pharmaceutical
Sciences .2012.
52. Milne D, Ralston N, Wallwork J. Zinc content of cellular components of blood: methods
for cell separation and analysis evaluated. Clinical chemistry. 1985;31(1):65-9.
53. Biambo H, Ejele O, Nwauche C. An evaluation of the Beckman-Coulter AcT 3-part
differential haematology analyzer in a tertiary hospital laboratory. Nigerian journal of
medicine: journal of the National Association of Resident Doctors of Nigeria.
2004;14(2):183-7.
32
54. Kendall R, Benoit E, Bogiages J, Bordenkircher R, Caple K, Chen L-L, et al.
Performance evaluation of the Abbott Cell-Dyn 1800 automated hematology analyzer.
Laboratory Hematology. 2003;9(3):143-52.
55. Chesbrough M. District Laboratory Practice in Tropical Countries (Part 1). Cambridge
University Press, Cambridge, UK; 2002.
56. World Health Organization. Obesity: preventing and managing the global epidemic:
WHO; 2000.
57. Kumar A, Chaudhary A. Kirshna's Descriptive Statistics:(Statistical Methods): Krishna
Prakashan Media.
58. Karyadi E, West CE, Schultink W, Nelwan RH, Gross R, Amin Z, et al. A double-blind,
placebo-controlled study of vitamin A and zinc supplementation in persons with
tuberculosis in Indonesia: effects on clinical response and nutritional status. The
American journal of clinical nutrition. 2002;75(4):720-7.
59. Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered
resistance to infection. The American journal of clinical nutrition. 1998;68(2):447S-63S.
60. Beck F, Prasad A, Kaplan J, Fitzgerald J, Brewer G. Changes in cytokine production and
T cell subpopulations in experimentally induced zinc-deficient humans. American
Journal of Physiology-Endocrinology And Metabolism. 1997;272(6):E1002-E7.
61. Ghulam H, Kadri SM, Manzoor A, Waseem Q, Aatif MS, Khan GQ, et al. Status of zinc
in pulmonary tuberculosis. Journal of infection in developing countries. 2009;3(5).
62. Khanna B, Kumar R, Mukerji P, Chowdhury A, Kamboj V. Plasma copper and zinc
levels in pulmonary tuberculosis. 1982.
63. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei X-F, et al. IL-6 is an
antiinflammatory cytokine required for controlling local or systemic acute inflammatory
responses. Journal of Clinical Investigation. 1998;101(2):311.
64. Lin PL, Rutledge T, Green AM, Bigbee M, Fuhrman C, Klein E, et al. CD4 T cell
depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent
infection is dependent on severity of tissue depletion in cynomolgus macaques. AIDS
research and human retroviruses. 2012;28(12):1693-702.
65. Roberts A, Sonnenberg M, Ordway D, Furney S, Brennan P, Belisle J, et al.
Characteristics of protective immunity engendered by vaccination of mice with purified
culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology.
1995;85(3):502.
33
66. Castilla J, Gutiérrez A, Guerra L, de la Paz JP, Noguer I, Ruiz C, et al. Pulmonary and
extrapulmonary tuberculosis at AIDS diagnosis in Spain: epidemiological differences and
implications for control. AIDS. 1997;11(13):1583-8.
67. Fiske CT, de Almeida AS, Shintani AK, Kalams SA, Sterling TR. Abnormal immune
responses in persons with previous extrapulmonary tuberculosis in an in vitro model that
simulates in vivo infection with Mycobacterium tuberculosis. Clinical and Vaccine
Immunology. 2012;19(8):1142-9.
68. Tahir R, Ullah I, Akram M. percentage of CD4 and CD8 t-lymphocytes in blood of
tuberculosis patients. J Ayub Med Coll Abbottabad. 2010;22(4).
69. Garibay-Escobar A, Gastélum-Aviña P, Velázquez C, Hernández J. Immunophenotyping
Analysis of Peripheral T and B Lymphocytes in Patients with Chronic Pulmonary
Tuberculosis. International Journal of Infectious Diseases. 2008;12:e476.
70. Tsao TC, Chen C-H, Hong J-h, Hsieh M-J, Tsao K-C, Lee C-H. Shifts of T4/T8 T
lymphocytes from BAL fluid and peripheral blood by clinical grade in patients with
pulmonary tuberculosis. CHEST Journal. 2002;122(4):1285-91.
71. Hasan Z, Zaidi I, Jamil B, Khan MA, Kanji A, Hussain R. Elevated ex vivo monocyte
chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary
tuberculosis. BMC immunology. 2005;6(1):14.
72. Ahmed SG, Ibrahim UA, Hassan AW. Hematological parameters in sick cell anemia
patients with and without priapism. Annals of Saudi medicine. 2006;26(6):439.
73. Lowe DM, Redford PS, Wilkinson RJ, O’Garra A, Martineau AR. Neutrophils in
tuberculosis: friend or foe? Trends in immunology. 2012;33(1):14-25.
74. Kerkhoff AD, Wood R, Lowe DM, Vogt M, Lawn SD. Blood Neutrophil Counts in HIV-
Infected Patients with Pulmonary Tuberculosis: Association with Sputum Mycobacterial
Load. PloS one. 2013;8(7):e67956.
75. AI-Omar I, Al-Ashban R, Shah A. Hematological Abnormalities in Saudis Suffering from
Pulmonary Tuberculosis and Their Reponce to the Treatment. Research Journal of
Pharmacology. 2009;3(4):78-85.
34
12. ANNEXS
Annex I; Laboratory procedure
Procedure I serum separation
1. Collect sample (preferably in glass tubes) and leave for an hour to allow it to clot.
2. Centrifuge the serum at 4000 -5000rpm for 5 minutes at room temperature.
3. Remove the serum from the clot by gently pipetting off into a clean tube using a glass
Pasteur or micro pipette.
4. Label with appropriate material.
5. Store at -20°C.
Procedure II sample transportation
1. Prepare materials , ice pack , ice box and sample rack
2. Add the ice pack in every side of the ice box
3. Cover the sample in the sample rack by plastic bag
4. Add the covered sample in the prepared ice pox ( sample container )
5. Add ice pack on the sample again and closed properly ice pox , and label with the
kind of sample with biohazard mark.
Procedure.III. Serum zinc level determination by 210 flam atomic absorption
spectroscopy
1. separate  serum from whole blood by centrifuge at 3000 rpm for five minutes
2. Adjust the instrument by doing calibration by known control of sample and prepare
calibration cure to make ready the machine for work
3. Dilute the serum in to 1:10 by distilled water to have  enough  amount of sample to
the machine
4. Give the diluted serum sample to the machine properly without discontinuous.
5. Red the absorbance deference from the  and obtain the net absorbance
6. Multiply the net absorbance by the factor to get result
Procedure, IV. Serum Albumin level determination procedure
1. Label test tubes Blank, Standard, Control and Patient
2. Pipette 1.5 ml of reagent into each tube
3. Transfer 0.01 ml (10 µl) of sample to respective tubes and mix and allow to stand at
room temperature for five (5) minutes
4. Zero spectrophotometer with the blank at 630 nm. (Wavelength range: 580 – 630 nm).
5. Read and record absorbencies of all tubes
6. Abs. of unknown × Concentration of Standard = Albumin g/dl Abs. of standard
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Procedure V. CD4, CD8, measurement procedure
1. Patient blood sample must be collected by k3 EDTA about 3ml
2. Label the tab of the reagent with patients number
3. Vortex the pair upside down for 5 second and up right for 5 second
4. Open the reagents with the coring station
5. Mix the patients whole blood by inverting the tube five times
6. Pipette 50µl of whole blood in to each of the two reagents tubes , change tips between
tubes
7. Cap the tubes and vortex up right for 5 seconds
8. Incubate the tubes for 60 to 120 minutes at room temperature ( 200 c to 250 c)
9. Uncap the tubes and pipette 50 µl of fixatives solution in to each of reagents tubes.
change tips between tubes
10. Recap the reagent tube with new caps and vortex up right 5 second
11. Run the tubes on FACS count instrument within 48 hours
Annex II.  Information sheet; English and Amharic version
Title of the Research Project
Immunological profile and Level of zinc on untreated tuberculosis patients in Gondar, North
west Ethiopia
Name of principal investigator:  Mulualem Lemma (BSC in medical laboratory)
Name of the Organization: University of Gondar College of Medicine and Health Science
School of Biomedical and Laboratory Sciences Department of immunology and Molecular
Biology.
Name of the Sponsor: University of Gondar
Introduction; the aim of this research is to measure zinc level and immunological profiles in
newly diagnosed TB patients. This information sheet and consent form is prepared for
explaining about the research to ask to participate in this research group.
Purpose of the project:. The purpose of this project is to measure zinc level and
immunological profiles in the participate blood in newly diagnosed tuberculosis patients in
Gondar, Ethiopia
Duration:
The duration of this study will be from February 2014 to April 2014
Procedure
1. The study participant will be a wared properly about the study
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2. If the study participant is allow himself ( herself) to be engaged in the study , he / she
will sign the consent form
3. The participants  will fill the questioner
4. Based on the questioner inclusion criteria, if the participants full fill all the inclusion
criteria he will give 15 ml of blood and stool sample
Risk and /or Discomfort
By participating in this research project you will not face any health problem other than a
slight discomfort especially during giving blood. Sample collection will take about 15
minutes.
Benefits
Your participation will help us to know whether zinc level and immunological profiles is low
or normal or not in newly diagnosed tuberculosis patients in Gondar. Therefore, knowing this
level will be good information about TB patients and the will be give a good source for other
research
Incentives/Payments for Participating
You will not be provided any incentives or payment to take part in this project.
Confidentiality
The information collected from this research will be kept confidential and information about
you that will be collected by this study will be stored in a file. In addition, it will not be
revealed to anyone except the investigator.
Right to Refusal or Withdraw
You have the full right to refuse from participating in this research. You can choose not to
response some or all the questions and this will not affect you from getting any kind of health
service. You have also the full right to withdraw from this study at any time you wish.
If you need additional information about this project you can contact either the principal
investigator or advisors by the following addresses.
MULUALEM LEMMA - Principal investigator
Cell phone no፡ +251-918 735 022 E-mail address; mulualeml@yahoo.com
DR. EBBA ABATE – main advisor
Cell phone no ፡ +251 9 11464024 E-mail: ebbaabate@yahoo.com
MR. MESERET WORKINEH - advisor
Cell phone no፡ +251- 9 18295706 Email: mwmesi@gmail.com
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Information sheet Amharic version
ለምርምሩ ተሳታፊዎች የሚሰጥመረጃ
የምርምሩፕሮጀክት ርዕስ ፡ በጎንር ዩኒቨርሲቲ ሆስፒታል አዲስ ከተመረመሩ የቲቢ በሽተኞች ላይ
የዚንክ እና የ ኢሚኖሎጂካል ፕሮፊይል ለመለካት የሚደረግ ጥናት፡፡
የተመራማሪዉ ስም ፡ሙሉአለም ለማ (የሁለተኛ ድግሪ ተማሪ)
የመስሪያ ቤቱ ስም ፡ በጎንደር ዩኒቨርሲቲ፣ የሕክምናና ጤና ሳይንስ ኮሌጅ፣የባዮሜዲካልና
ላቦራቶሪ ትምህርት ቤት፣ ኢሚኖሎጂ እናሞሎኪውላር ባዮሎጂ ትምህርት ክፍል፡፡
መግቢያ
አዲስ ከተመረመሩ የቲቢ በሽተኞች ላይ የዚንክ እና የኢሚኖሎጂካል ፕሮፊይልን ለመለካት
ጥናት ላይ ነኝ፡፡ እርስዎፈቃደኛ ከሆኑ በጥናቱ እንዲሳተፍ ተጋብዘዋል፡
ጥናትና ምርምሩ ዓላማ
የጥናትና ምርምሩ ዓላማ አዲስ ከተመረመሩ የቲቢ በሽተኞች ላይ የዚንክ እና የኢሚኖሎጂካል
ፕሮፊይልንመለካት ነዉ፡፡
ጥናትና ምርምሩ የሚፈጀው ጊዜ፡ጥናትና ምርምሩን ሰርቶ ለማጠናቀቅ አራት ወር ይፈጃል፡፡
ጥናትና ምርምሩሒደት
1. በመጀመሪያ ጥናትዉስጥ የሚሳትፉ ሰወች ስለጥናቱማብራሪያ ያደረግላቸዋል
2. ከማብራሪዉ በላ ተሳታፊ ለመሆን ከተስማሙ የመስማሚያ ፎርሙ ላያ በፊርማቸዉ
ያረጋግጣሉ
3. በወረቀት የተዘጋጀዉንመጠይቅ ይሞላሉ
4. በመጠይቁ መሰረት ሙሉ ለሙሉ የጥናቱ ተሳታፊ ከሆኑ የደም እና የአይነምድር ናሙና
ይሰጣሉ
የሚያስከትለዉ ጉዳት
በጥናትና በምርመሩ በመሳተፍዎ ከመጠነኛ የእጅ ህመም ዉጭ ምንም አይነት የጤና ችግር
አያስከትልም፡፡ ለምርምሩ ናሙና ለመሰብሰብ አስራአምስት ደቂቃ ብቻ ይወስዳል፡፡
ለተሳታፊዉወይም ለህብረተሰቡ የሚሰጠዉጥቅም
የጥናቱና ምርምሩ ዉጤት የዚንክ እና የኢሚኖሎጂካል ፕሮፊይል መጠን ዝቅተኛ ወይንም
በቂ ወይንም ከፍተኛ መሆኑን ለማወችላል፡፡ ያይህንን መጠን ማወቅ ለትቢ ታካሚዎች
እንደጥሩ መረጃ ሁኖ የጠቅማል፡፡ ለሊሎች ጥናቶች እንደ ጥሩ መረጃ በመሆን ይጠቅማል
የካሳ ክፍያ
ዕርስዎ በዚህ ጥናትና ምርምር በመሳተፍዎምንም አይነት የማካካሻ ክፍያ አይከፈለዎትም፡፡
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ሚስጢራዊነት
ከዕርስዎ የተወሰደማንኛዉምመረጃሚስጥራዊነቱ የተጠበቀ ነዉ፡፡ ከተመራማሪውውጭማንም
ሰውመረጃውን እንዲያውቀው አይደረግም፡፡
እራስን ከጥናቱ የማግለልመብት
ዕርስዎ በዚህ ጥናትና ምርምር መካተት በዕርስዎ ሙሉ ፈቃድ ሲሆን በጥናቱ
ያለመካተትም ሆነ ከተካተቱም በኃላ ያለምንም ቅድመ ሁኔታ ፈቃደኝነተዎን የማንሳት
መብትዎ ሙሉ በሙሉ የተጠበቀ ነዉ፡፡ያልፈለጉትን ጥያቄ ያለመመለስ መብት አለዎት፡፡
ተጨማሪ መረጃ ከፈለጉ
ስለጥናትና ምርምሩ ማንኛዉን አይነት ጥያቄ ካለዎት በማንኛዉም ሰዓት ተመራማሪዉንም
ሆነ አማካሪዎችን በሚከተለዉ አድራሻ ማግኘት ይችላሉ፡፡
ሙሉአለም ለማ -ተመራማሪ
ስልክ ቁጥር፡ +251- 09 18735022
ኢሜይል mulualeml@yahoo.com
ዶ/ር ኤባ አባተ - ዋና አማካሪ
ስልክ ቁጥር፡ +251 9 11464024
ኢሜይል፤ ebbaabate@yahoo.com
መሰረት ወርቅነህ- አማካሪ
ስልክ ቁጥር፡ +251- 09 18295706
ኢሜይል ፤ mwmesi@gmail.com
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Annex IV.  Consent form; English and Amharic version
I have been informed about a study that plans determine the level of zinc level, Albumin level
, total protein level and immunological profiles among newly diagnosed pulmonary
tuberculosis patients in Gondar, which will help in investigating the extent to which zinc lvel
affect the host immune immunological profiles response to tuberculosis. For the study I have
been requested to give a blood and stool sample. I am informed that experienced health
professionals according to the established aseptic procedure would do the blood and stool
collection. Based on this, I have agreed to participate in the study. The investigator also
informed me that the laboratory findings would be kept confidential and I can withdraw my
consent to participate in the study at any stage.
I have been given enough time to think over before I signed this informed assent. It is
therefore, with full understanding of the situation that I gave my informed assent and will
cooperate in the course of the study.
Name of study participant-------------------------------------signature----------date------------
Name of investigator-------------------------------------------signature----------date------------
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Amharic version of consent form
የስምምነት ቅፅ
ያህ የጥናት በአዲስ የቲቢ በሽተኞች ላያ የዚንክ እና የኢሚኖሎጂካል ፕሮፊይል
መጠንን ለመለካትየሚደረገመሆኑንአዉቂ
ስለ ጥናቱ ዓላማ ምርምር እና ሒደት በሚገባ ተገልጾልኝ ምንም ምክንያት ሳያስፈልገኝ
ከጥናቱ ለማቆረጥ እንደምችል ተረድቻለሁ፡፡ ይህ የስምምነት ቅፅ በአፍ መፍቻ ቋንቋዬ
አንብቤ/ ተነቦልኝ በትክክል ተረድቼ በራሴ ፈቃደኝነት በጥናቱ እንድካፈል ተስማምቻለሁ፡፡
ለዚህም በፊርማዬ አረጋግጣለሁ፡፡
የጥናቱ ተሳታፊ ስም-----------------------------------ፊርማ--------------------ቀን------/------/-----
የተመራማሪዉ ስም--------------------------------------ፊርማ--------------------ቀን------/------/----
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Annex V. Questionnaire; English and Amharic version
This questionnaire is prepared to collect socio demographic and clinical data from newly
diagnosed tuberculosis patients for the study which aims to determine zinc level and
immunological profile in newly diagnosed tuberculosis patients in Gondar. You are selected
to participate in this study just by chance. It will take about 15 minutes to interview
questionnaire.
Questionnaire code number _________________
woreda____________
Town _____________
Kebelle ____________
Tell phone____________
Pare I: socio - demographic data status
101 Age __________
102 Sex A. Male
B. Female
103 Residence A. Urban
B. Rural
104 Occupation A. Student
B. office work
C. daily labourer
D. farmer
E. Hose wife
105 Religion A. Orthodox
B. Protestant
C. Muslim
D. Other specify_____
106 Level of education A. Illiterate
B. High school
C. Diploma
D. First degree
E. Above first degree
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Part II: Clinical data
s.no Questions Response
201 Do you have diseases other than
tuberculosis?
1. Yes
2. No
202 If your response for question number 12
is yes, what type of disease you have?
1. Malaria
2. Hepatitis
3. Kalazar(coutanousleishimania)
4. Cancer
5. Others specify ____________
203 If she is female are you pregnant? 1. Yes
2. No
204 Q no 203 is no, are you taking
contraceptive?
1. Yes
2. No
205 Do you have surgery within the past one
month?
1. Yes
2. No
206 Do you have a blood loss or donate blood
within the past three month?
1. Yes
2. No
207 Is this tuberculosis for the first time? 1. Yes
2. No
208 Do you have a history of diabetes
mellitus?
1. Yes
2. No
209 Do you have known chronic organ
problem?
1. Yes
2. No
2010 If Q2011 answer yes which organ? 1. Liver
2. Kidney
3. Bone marrow
4. Heart
Laboratory findings record sheet
1. Serum zinc level ____________
2. Albumin level______________
3. CD4 count_________________
4. CD8 count_________________
5. Nutrophile__________________
6. Monocyte__________________
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Amharic version of questionnaire
መጠይቅ:
ይህ መጠይቅ የተዘጋጀዉ በሰሜን ኢትዮጲያ፣ በጎንደር ከተማ፤ በጎንደር ዩኒቨርስቲ
ሆስፒታል አዲስ የሳንባ ቲቢ በሽታ ከተገኘባቸው ታማሚዎች ዉስጥ የዚንክ እና
የኢሚኖሎጂካል ፕሮፊይል መጠን እና ስለታማሚዉ ማንነት የሚመለከቱ ሁኔታዎችን
መረጃ ለመሰብሰብ ነዉ፡፡
መጠይቅ
የመጠይቅ ቁጥር------------------------------
ወረዳ------------------------------------------
ክትማ-----------------------------------------
ቀበሊ-------------------------------------------
ስለተሳታፊው ማንነት መረጃን የሚመለከቱ መጠየቆች
ተ. ቁጥር መጠይቅ መልስ
101 እድሜ
102 ጾታ 1. ወንድ
2. ሴት
103 የሚኖርበት አካባቢ 1. ከተማ
2. ገጠር
104 ስራ 1. ተማሪ
2. የቢሮ ሰራተኛ
3. የቀን ሰራተኛ
4. ገበሬ
5. የቤት እመቤት
105 ሐይማኖት 1. ኦርቶዶክስ
2. ፕሮቴስታንት
3. እስላም
4. ሌላ(ይገለጽ ----------------)
106 ትምህርት ደረጃ 1. ያልተማረ
2. ሁለተኛ
3. ዲፕሎማ
4. የመጀመሪያ ደግሪ
5. ከድግሪ በላይ
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የበሽታ ምልክትና ተዛማጅ ሁኔታዎች
ተ. ቁጥር መጠይቅ መልስ
201 ከቲቢ በሽታ ዉጪ ታመዉ ያዉቃሉ? 1. አዎ
2. አላውቅም
202 ለ201ኛዉ ጥያቄ መልስዎ አዎ ከሆነ ምን
ዐይነት በሽታ ነበር ታመዉ የነበሩት
1. ወባ
2. የጉበት በሽታ
3. ካላዛር( ቁንጭር)
4. ካንሰር
5. ሌላ (ይገለጽ--------
203 ሲት ከሆነች . ነፊሰጡር ነዉተ 1. አዎ
2. አያደለሁም
3. አላውቅም
204 ተራቁጥር 203 ለ ከሆነ የእርግዝና
መቆጣጠሪያ ያወስዳሉ?
3. አዎ
4. አልወስድም
205 በዚህ አንድ ወር ዉስጥ ቀዶ ህክምና
ተደርጎልዎተ ያዉቃል
1. አዎ
2. አያውቅም
206 በዚህ 3 ወር ዉስጥ የደም መፈሰስ
ወያንም ደም መለገስ አጋጥመዎታል
1. አዎ
2. አያዉቅም
207 ለመጀመሪያ ጊዚ ነዉ ትቢ የያዘዎት 1. አዎ
2. አደለም
208 የስኩአር በሽታ አለበዎት 1. አዎ
2. አላውቅም
209 የዉስጥ አካል ክፍል ችግር አለበዎተ 1. አዎ
2. አላውቅም
2010 የተቁጥር መልስ አዎ ከሆነ የትኛዉ ነዉ 1. የጉነበት
2. የእንኩለላሊት
3. የየአጥንት መቅን
4. የልብ
Laboratory findings record sheet
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3. CD4 count_________________
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